Rita Numerof, Contributor

Author's posts

Retail Health Is Booming: Is It What The Doctor Ordered Or A Symptom Of A Bigger Problem?

CVS and Walgreens have been in the space for years, gradually providing services once exclusive to the aging model. In so doing, they have shone a spotlight on the inefficiencies and lack of sophistication in traditional healthcare delivery to a more d…

Monkeypox Or Monkey Business: The Administration’s Love Affair With Control

Why the government issued mask guidance with respect to Monkeypox in the first place is anyone’s guess, but it certainly doesn’t reflect what the health experts are telling us. Unlike Covid-19, we know a lot more about this virus, who it impacts and ho…

Baby Formula Blues: The Latest Regulatory Fiasco Reveals Problems Bigger Than The Recall Itself

As it is, infant formula is very difficult to manufacture and to keep compliant with FDA standards. The industry recognized the implications of the shutdown of the Abbott Nutrition plant and yet the FDA and the White House failed to connect on the issue.

Green Shoots Of New Innovation Or Invasive Weeds?

This new class of healthcare innovators equipped with technology, research methods, and the capacity to scale is poised to demonstrate that a new model of care can succeed. Will these innovators be seen as the green shoots they are, or will they be tar…

Pay A Little, Get A Little: Medicare’s Annual Wellness Visit Misses The Mark

Expanding wellness checks to everyone is a band-aid solution to improving overall health. While a wellness visit may help some on the margins, what many seniors under Medicare Plan B receive will be of little benefit.

A New 988 Suicide Prevention Hotline Number Is About To Launch, But It Won’t Work Unless Key Players Rally For Its Success

While 988 promises to connect sufferers to providers, that is only part of the answer to lowering suicide rates. It would be too pat to assume the hotline can do that on its own and changes on the supply side are also needed or we won’t see much improv…

Why Pharma Should Commit To Population Health

Covid-19 is not the first pandemic to strike our society, nor will it be the last. Will this experience be enough to convince leaders to embrace a population health approach?

US Pharmaceutical Supply At Increased Risk Along With Oil, Gas, And Food

While oil and gas are making the headlines, shortages of Active Pharmaceutical Ingredients (APIs), the chemical inputs that make medicines and antibiotics work, may be a bigger threat if we do not actively work diligently towards preventing it.

Is Telehealth Here To Stay, Or Just A Mirage?

With the possibility of Covid being seen in the rearview mirror, we are at a crossroads — to formalize the new realities that make telehealth so attractive, or to reinstate the restrictions that contributed to the sclerotic model we had before the pand…

With Covid Behind Us, Can We Turn Back To Fixing Our Broken Healthcare Model?

Bringing about the best outcome will require a fundamentally different business model that redefines how work gets done, by whom, and how people are compensated. While it’s not that hard to conceptualize, it’s very different from the status quo that’s …